Article

Cross-reactive neutralization of SARS-CoV-2 by serum antibodies from recovered SARS patients and immunized animals

2020-04-21

Abstract excerpt

The current COVID-19 pandemic, caused by a novel coronavirus SARS-CoV-2, poses serious threats to public health and social stability, calling for urgent need for vaccines and therapeutics. SARS-CoV-2 is genetically close to SARS-CoV, thus it is important to define the between antigenic cross-reactivity and neutralization. In this study, we firstly analyzed 20 convalescent serum samples collected from SARS-CoV infe...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 6f6a606b-f542-5073-a676-eb6797f0683e
DOI: 10.1101/2020.04.20.052126

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Cross-reactive neutralization of SARS-CoV-2 by serum antibodies from recovered SARS patients and immunized animalsDOI 10.1101/2020.04.20.052126Read

Broad cross-neutralizing antibodies against animal-associated sarbecoviruses generated by SARS-CoV-2 infection and vaccination in humansSemantic proximity Read

Isolation and Characterization of Cross-Neutralizing Coronavirus Antibodies from COVID-19+ SubjectsSemantic proximity Read

Sequential immunization with SARS-CoV-2 RBD vaccine induces potent and broad neutralization against variants in miceSemantic proximity Read

Cross-reactive antibodies after SARS-CoV-2 infection and vaccinationSemantic proximity Read

A designed overlapping variant immunogen pool elicits broad sarbecovirus neutralizationSemantic proximity Read

Cross-Reactivity of SARS-CoV Structural Protein Antibodies Against SARS-CoV-2Semantic proximity Read

SARS coronavirus vaccines protect against different coronavirusesSemantic proximity Read

Novel S2 subunit-specific antibody with broad neutralizing activity against SARS-CoV-2 variants of concernSemantic proximity Read

Recombinant Fc-fusion vaccine of RBD induced protection against SARS-CoV-2 in non-human primate and miceSemantic proximity Read

The recombinant subunit vaccine RBD-Fc, consisting of SARS-CoV-2 RBD and human IgG Fc as an immunopotentiator, elicits robust neutralizing antibody responses against SARS-CoV-2 infectionSemantic proximity Read

Enhanced protective immunity against SARS-CoV-2 elicited by a VSV vector expressing a chimeric spike proteinSemantic proximity Read

Cross-reactivity of SARS-CoV structural protein antibodies against SARS-CoV-2Semantic proximity Read